Amova Asset Management Americas Inc. cut its position in shares of Pacific Biosciences of California

In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.36, indica

MENLO PARK, Calif. , July 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it

Pacific Biosciences of California (PACB) concluded the recent trading session at $1.49, signifying a

PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressure

Pacific Biosciences of California (PACB) closed the most recent trading day at $1.66, moving 1.19% f

Pacific Biosciences of California (PACB) closed at $1.68 in the latest trading session, marking a -2

Pacific Biosciences of California (PACB) closed the most recent trading day at $1.31, moving 2.96% f

On Wednesday, June 10, 2026, Ark Invest sold $7.8M in Robinhood shares Wednesday while adding 141,50

PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressure

Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine

PACB expands HiFi sequencing reach with commercial availability of SPRQ-Nx for Revio, lowering costs

New Revio multi-use SMRT Cells reduce sequencing costs by 30% compared to previous SPRQ chemistry wh

MENLO PARK, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of h

PacBio teams with Blank Bio after its $7.2M seed round, using HiFi long reads to build RNA AI models

Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level predict

SAN FRANCISCO--(BUSINESS WIRE)--Blank Bio Announces Seed Financing and Strategic Collaboration with

Barclays analyst Luke Sergott maintains Pacific Biosciences (NASDAQ:PACB) with a Underweight and

Multinational study shows how one comprehensive genomic workflow and secure data collaboration may h

Pacific Biosciences of California NASDAQ: PACB reported first-quarter 2026 revenue of $37.2 million,

PacBio beats Q1 earnings estimates as consumables growth and cost cuts offset flat revenue and a wea

Pacific Biosciences of California, Inc. (PACB) Q1 2026 Earnings Call Transcript

Pacific Biosciences (NASDAQ:PACB) sees FY2026 sales of $165.000 million-$175.000 million vs $173.371

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.12) per share which beat the anal

The protocol will be formally presented at the upcoming American Association for Cancer Research (AA

Barclays analyst Luke Sergott downgrades Pacific Biosciences (NASDAQ:PACB) from Equal-Weight to U

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.12) per share which beat the anal

PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, tod

PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today anno

PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today ann

PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, ann

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 wil

Barclays analyst Luke Sergott maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and

Piper Sandler analyst David Westenberg maintains Pacific Biosciences (NASDAQ:PACB) with a Neutral

Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomi

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for it

  Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua